Latest filing published 01 Oct 2026 for COSCIENS Biopharma Inc.. Read the official filing
No signal scores available.
David Spear appears in our data through filings on COSCIENS Biopharma Inc. shares, published by SEDI. Over a trading history stretching from 30 May 2025 to 16 September 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 October 2026 came the latest disclosure, a transaction in COSCIENS Biopharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations